±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 582  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

AnnF

°æÖ÷ (ÎÄ̳¾«Ó¢)

[ÇóÖú] ÇóÖú·­ÒëÒ»¶ÎÒ©Îﻯѧ·½ÃæµÄÓ¢ÎÄ£¨Ó¢ÒëÖУ©£¬»Ò³£ÖØÐ»£¡£¡£¡

1. Introduction

Peptides are among the most versatile bioactive molecules e.g.many peptide hormones and analogous short peptides exert their action by binding to membrane receptors [1]. Peptides and their derivatives may also exhibit a broad spectrum of biological activ-ities such as antimicrobial [2], antiviral, and anticancer activities[3]. However, most natural peptides are composed of L -form a-amino acids and because of the ubiquitous prevalence of pepti-dases, they have limited biostability, and consequently low bioavailability. To overcome this problem, stable and at the same time biologically active pseudo-peptides have been developed. These novel compounds open up new perspectives in drug design by providing an entire range of highly speci fi c and non-toxic
pharmaceuticals. With growing application on their synthesis and bioactivity, chemists and biologists in recent years have directed considerable attention on the research of pseudo-peptide derivatives mimicking the pharmacophore and thus the activity of the original peptide [4,5]. As isosteres of peptides, phosphono-peptides containing a transition state analogue of the hydrolysis of the amide bond represent another attractive approach for the preparation of proteolytically stable peptides [6]. In addition to increased stability, incorporation of a phosphonate moiety into the peptide sequence also provides access to additional binding interactions within the transition state conformation of the enzyme/substrate complex [7]. A wide range of phosphonopep-tides have been used to design very effective protease inhibitors[8 -10 ]. However, since there are only a limited number of economically viable chemicals available for practical application in biological science or agriculture [11] , a great deal of scope still lies ahead for further research in this field. In this context, in order to find broad spectrum biologically active pseudo-peptide thiourea, we have previously described preparation of certain chiral thio-urea derivatives containing a-aminophosphonate moiety with signifi cant antiviral activity [12]. Herein, we further turned our attention to prepare novel compounds with enhanced antitumor activities by incorporating a-aminophosphonate moiety at the 1 or 3-position of pseudo-peptide thiourea. The primary aim of this study is to synthesize the title compounds and study their anti-tumor activities for the development of a new inhibitor to PC3, Bcap37 and BGC823 cells. To the best of our knowledge, this is the first report on the synthesis and antitumor activity of pseudo-peptide thioureas containing a-aminophosphonate moiety.

Ó¢ÎÄÔ­ÎÄ.png



[ Last edited by AnnF on 2012-12-29 at 17:30 ]

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

myprayer

ר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)

ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
°®ÓëÓêÏÂ: ½ð±Ò+2 2012-12-29 20:53:27
AnnF: ½ð±Ò+5, ·­ÒëEPI+1, ¡ïÓаïÖú, Ï£ÍûÓиü׼ȷµÄÒëÎÄ£¬O(¡É_¡É)Oлл£¡ 2012-12-29 22:34:44
ëÄÊÇ×îͨÓõÄÉúÎï»îÐÔ·Ö×Ó£¬ÀýÈçÐí¶àëÄÀà¼¤ËØºÍͨ¹ýºËĤÊÜÌå½áºÏÀàËÆµÄ¶ÌëÄ [ 1 ]¡£ëļ°ÆäÑÜÉúÎïÒ²¿ÉÄܱíÏÖ³ö¹ã·ºµÄÉúÎï»îÐÔµÈÀýÈ翹¾ú£¬¿¹²¡¶¾£¬¿¹°©»îÐԵȡ£È»¶ø£¬×î×ÔÈ»µÄ¶àëÄÊÇÓÉL-¦Á-°±»ùËᣬÒòΪÎÞ´¦²»ÔÚµÄÁ÷ÐÐëÄøÉúÎïÎȶ¨¶¨ÐÔÓÐÏÞ£¬Òò´ËÉúÎïÀûÓöȵ͡£ÎªÁ˿˷þÕâ¸öÎÊÌ⣬ÒÑ¿ª·¢ÁËÎȶ¨²¢ÇÒͬʱ¾ßÓÐÉúÎï»îÐÔµÄαëÄ¡£ ÕâЩл¯ºÏÎ↑±ÙÁËеÄǰ¾°Ò©ÎïÉè¼Æ²¢ÎªÆäÌṩÁËÒ»ÕûÌ׷dz£Ã÷È·µÄºÍÎÞ¶¾µÄÒ©Îï¡£ Ëæ×ÅÔ½À´Ô½¶àµÄÓ¦ÓõĺϳɺÍÉúÎï»îÐÔ£¬»¯Ñ§¼ÒºÍÉúÎïѧ¼Ò×î½ü¼¸ÄêÔÚÑо¿Î±ëÄÑÜÉúÎïµÄҩЧÏàµ±ÖØÊÓ£¬´Ó¶øÄ£·Â»îÐÔµÄԭʼëÄ[ 4 , 5 ]¡£ ×÷Ϊµç×ÓµÈÅÅÎïëÄ£¬°±»ùÁ×Ëáëĺ¬Óйý¶É̬ÀàËÆÎïË®½âõ£°·½áºÏÊÇÁíÒ»¸öÓÐÎüÒýÁ¦µÄ·½·¨£¬Äܹ»ÓÃÓÚÖÆ±¸µ°°×Ë®½âÎȶ¨ëÄ[ 6 ]¡£ ³ýÁËÄÜÔö¼ÓÎȶ¨ÐÔÍ⣬ÔÚ¹ý¶É̬¹¹ÏóµÄø/µ×ÎïÖУ¬Ò»²¿·ÖµÄ¶àëÄÐòÁÐÄÜÌṩ¶îÍâµÄÔ¼ÊøÁ¦µÄ¡£·¶Î§¹ã·ºµÄ°±»ùÁ×ËáëÄÒÑÓÃÓÚÉè¼Æ·Ç³£ÓÐЧµÄµ°°×øÒÖÖÆ¼Á[ 8 - 10 ]¡£ È»¶ø£¬ÓÉÓÚÖ»ÓÐÓÐÏÞÊýÁ¿µÄ¾­¼ÃÉÏ¿ÉÐеĻ¯Ñ§Æ·¿ÉÓÃÓÚʵ¼ÊÓ¦ÓÃÉúÎï¿ÆÑ§»òũҵ[ 11 ]£¬´ó·¶Î§µÄÓ¦ÓÃÈÔÐèÒª½øÒ»²½Ñо¿¡£ÔÚÕâ·½Ãæ£¬ÎªÁËѰÕÒ¹ãÆ×ÉúÎï»îÐÔµÄαëÄÁòë壬֮ǰÎÒÃÇÒѾ­Ñо¿ÖƱ¸Ä³Ð©ÊÖÐÔÁòë壨ÓÃÓÚÖÎÁƼ׿º¡¢ÕÕÏàÊõµÈ£© ÑÜÉúÎﺬÓÐA-°±»ùì¢Ëáõ¥»ùÍųɷ־ßÓÐÏÔÖøµÄ¿¹²¡¶¾»îÐÔ[ 12 ]¡£ ÔÚ´Ë£¬ÎÒÃǽøÒ»²½Ñо¿ÁËÔÚ1»ò3λαëÄÁòëå¾ßÓÐÔöÇ¿¿¹Ö×Áö»îÐÔ½áºÏA-°±»ùì¢Ëáõ¥»ùÍųɷֵÄÐµĻ¯ºÏÎï¡£ÕâÏîÑо¿µÄÖ÷ҪĿµÄÊǺϳɱêÌ⻯ºÏÎ²¢Ñо¿ÄÜÔÚǰÁÐÏÙ°©£¬bcap37ºÍBGC 823ϸ°ûÖÐʹ¾ßÓÐÆä¿¹Ö×Áö»îÐÔ²¢ÄÜ¿ª·¢ÐµÄÒÖÖÆ¼Á¡£¾ÝÎÒÃÇËùÖª£¬ÕâÊÇÊ״α¨¸æÁ˺¬ÓÐA-°±»ùì¢Ëáõ¥Áòëå»ùÍźϳɺͿ¹Ö×Áö»îÐÔµÄαëÄ¡£
2Â¥2012-12-29 18:54:25
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ AnnF µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸aÇø211£¬085601-307·ÖÇóµ÷¼Á +6 µ³¼ÎºÀ 2026-03-31 11/550 2026-03-31 13:39 by JourneyLucky
[¿¼ÑÐ] 328Çóµ÷¼Á +3 ÅôÅôÅöàØàØ 2026-03-24 3/150 2026-03-31 10:56 by sophie2180
[¿¼ÑÐ] Çóµ÷¼Á +4 ÑÐs. 2026-03-25 4/200 2026-03-31 10:05 by fmesaito
[¿¼ÑÐ] 08¹¤¿Æ£¬295£¬½ÓÊÜ¿çרҵµ÷¼Á +6 lmnlzy 2026-03-30 6/300 2026-03-31 10:04 by cal0306
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤µ÷¼Á +16 kikiki7 2026-03-30 16/800 2026-03-31 10:03 by ÂÈ»¯ÑÇÏõõ£
[¿¼ÑÐ] 0817»¯¹¤Ñ§Ë¶µ÷¼Á +7 ŬÁ¦Éϰ¶ÖУ¡ 2026-03-31 7/350 2026-03-31 09:58 by nalakaiqi
[¿¼ÑÐ] 22408 359·Öµ÷¼Á +4 Qshers 2026-03-27 8/400 2026-03-31 08:53 by Qshers
[¿¼ÑÐ] 08¹¤¿ÆÇóµ÷¼Á286 +5 tgs_001 2026-03-28 5/250 2026-03-31 08:18 by Ò»Ö»ºÃ¹û×Ó?
[¿¼ÑÐ] ²ÄÁÏÇóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó×Ü·Ö298·Ö£¬Ç°Èý¿Æ223·Ö +10 dongfang59 2026-03-27 10/500 2026-03-30 23:42 by ¹û¹ûÂèßä
[Óлú½»Á÷] ¿¼Ñе÷¼Á +8 watb 2026-03-26 8/400 2026-03-30 18:40 by 544594351
[¿¼ÑÐ] 292Çóµ÷¼Á +13 ÊÇåû×ÓÒ²ÊÇÑÐ×Ó 2026-03-30 13/650 2026-03-30 18:01 by СÐì0109
[¿¼ÑÐ] 284Çóµ÷¼Á +14 junqihahaha 2026-03-26 15/750 2026-03-30 14:12 by ̽123
[¿¼ÑÐ] ÉúÎï¼¼ÊõÓ빤³Ì +7 1294608413 2026-03-25 8/400 2026-03-30 11:36 by ÌÆãå¶ù
[¿¼ÑÐ] 318Çóµ÷¼Á +7 ³Â³¿79 2026-03-30 7/350 2026-03-30 10:49 by ̽123
[¿¼ÑÐ] 298Çóµ÷¼Á +4 ÖÖÊ¥´Í 2026-03-28 4/200 2026-03-29 08:42 by q1092522407
[¿¼ÑÐ] 070300Çóµ÷¼Á306·Ö +4 26ÒªÉϰ¶ 2026-03-27 4/200 2026-03-28 13:06 by ÌÆãå¶ù
[¿¼ÑÐ] 0856µ÷¼Á +5 ÇóÇóÈÃÎÒÓÐÊé¶Á° 2026-03-26 6/300 2026-03-27 15:12 by caszguilin
[¿¼ÑÐ] 298µ÷¼Á +3 jiyingjie123 2026-03-27 3/150 2026-03-27 11:57 by wxiongid
[¿¼ÑÐ] ¡¾2026¿¼Ñе÷¼Á¡¿ÖÆÒ©¹¤³Ì 284·Ö ÇóÏà¹Ø×¨Òµµ÷¼ÁÃû¶î +4 Ô¬Û¼Û¼ 2026-03-25 8/400 2026-03-25 14:32 by lbsjt
[¿¼ÑÐ] 340Çóµ÷¼Á +5 »°Ã·ÌÇ111 2026-03-24 5/250 2026-03-25 06:53 by ilovexiaobin
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û